Product News
First Large Hospital System Converts to Vestagen’s New VESTEX® Protected Attire Designed to Help Fight Pathogen Transmission

First Large Hospital System Converts to Vestagen’s New Vestex® Protected Attire Designed to Help Fight Pathogen Transmission

Deal marks company’s biggest deployment of groundbreaking healthcare worker safety enhancing uniforms

ORLANDO, Fla. – June 24, 2014 – Vestagen Technical Textiles, Inc. today announced it has finalized a five-year, multi-million dollar contract to provide Baptist Health of Jacksonville, Fla. with white coats and scrubs protected by Vestagen’s proprietary Vestex® fabric. Vestex combines breathability, fluid-repellency and antimicrobial activity to reduce the risk of pathogen transmission on soft-surfaces. The agreement marks the largest contract in Vestagen’s history.

“This large-scale adoption of Vestex protected attire is not only a major milestone for our company it is also a major milestone in U.S. healthcare. Baptist Health is making the first widespread commitment to proactively improve healthcare worker and patient safety by utilizing advanced textile technology,” said Ben Favret, president and CEO of Vestagen. “Vestagen is absolutely privileged to partner with a leading hospital system like Baptist Health to demonstrate that what healthcare workers wear should serve as a barrier against harmful pathogens.”

Vestex fabric is fluid-repellant to reduce the acquisition and retention of contaminants and made with an embedded antimicrobial to inhibit the growth of bacteria on the fabric. It is the first fabric clinically proven to minimize the acquisition and retention of pathogens. According to a clinical study published in the journal of Infection Control and Hospital Epidemiology1, ICU staff wearing Vestex had greater than 99.99 percent fewer methicillin-resistant Staphylococcus aureus (MRSA) organisms present on their uniforms, both before and after a shift, compared to workers wearing traditional non-protective uniforms. The fabric is also breathable with the ability to quickly wick away moisture from the inside, providing comfort to the wearer and a constant professional appearance.
1 G. Bearman, et al., A crossover trial of antimicrobial scrubs to reduce methicillin-resistant Staphylococcus aureus burden on healthcare worker apparel. Infection Control and Hospital Epidemiology. 2012: Vol. 33; No. 3.

Baptist Health is investing in its conversion to Vestex uniforms as part of a new system-wide effort to leverage technology to enhance their culture of safety. The uniforms will be distributed to more than 6,000 staff members involved in direct patient care across its five-hospital system starting on July 9. Baptist Health also plans to extend Vestex protection to patients later this year through the deployment of new patient apparel custom designed in collaboration with Vestagen to enhance patient protection and dignity.

“Our decision to protect our staff with Vestex attire is an investment in enhancing the culture of safety for our employees and patients,” said Diane Raines, DNP, RN, NEA-BC, senior vice president and chief nursing officer at Baptist Health. “We believe the proactive steps we are taking to minimize the role attire can play in transmitting pathogens will soon be the new standard in preventing unexpected exposures. This is part of our commitment to change health care for good. As early adopters of this new technology we will share what we learn with others in our industry.”

“Healthcare workers are exposed to some of the most dangerous work environments and need better protection from the body fluids and harmful contaminants they encounter every day,” added Favret. “The progressive action Baptist Health is taking to prioritize staff and patient safety in this way sets a strong precedent for other healthcare facilities to follow.”

Baptist Health’s efforts also support Vestagen’s goal to inform healthcare workers about the important role their uniforms can play in pathogen transmission. To draw further attention to this issue, Vestagen recently launched a “Keep the Coat” campaign to raise awareness about the transmission potential of non-protective uniforms and the risk of contaminating provider’s street clothes if the protective qualities of the storied white coat are removed during patient interaction.

For more information about the “Keep the Coat” campaign and to join the discussion about mobile soft-surface contamination, please visit For more information about Vestagen and Vestex, please visit

About Vestagen and VESTEX®
Vestagen Technical Textiles develops and markets advanced performance textile products and technologies. Its VESTEX® active barrier technology is the first to combine fluid repellent, antimicrobial and breathability properties in one fabric for everyday protection from unanticipated fluid exposure and pathogen transmission. VESTEX is proven in a clinical setting to prevent or reduce the acquisition and retention of contaminants on clothing, reducing methicillin-resistant Staphylococcus aureus (MRSA) on the fabric by 99.99% compared to traditional uniforms. VESTEX is also comfortable, durable and affordable. Product lines, including lab coats, uniforms and patient apparel, are manufactured and sold directly by Vestagen, its retail partners and select distributors. VESTEX fabric is also available for use in garment production by approved licensees. For more information about Vestagen and VESTEX, visit

Rachel De Jesus

BLL Partners
Barbara Lindheim

Posted on June 24, 2014 in Product News, Vestagen, Vestex

Share the Story

Back to Top